Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 5.71 1.06% 0.06
MCRB closed up 1.06 percent on Friday, January 18, 2019, on 58 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MCRB trend table...

Date Alert Name Type % Chg
Jan 18 Doji - Bullish? Reversal 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Wide Bands Range Expansion 1.06%
Jan 17 Overbought Stochastic Strength 1.06%
Jan 16 Weak + Overbought Other -4.03%
Jan 16 Outside Day Range Expansion -4.03%
Jan 16 Wide Bands Range Expansion -4.03%
Jan 16 Overbought Stochastic Strength -4.03%
Jan 15 NR7 Range Contraction -7.90%
Jan 15 Weak + Overbought Other -7.90%

Older signals for MCRB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Is MCRB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.345
52 Week Low 4.42
Average Volume 98,699
200-Day Moving Average 7.6296
50-Day Moving Average 6.8034
20-Day Moving Average 5.416
10-Day Moving Average 5.923
Average True Range 0.4351
ADX 22.34
+DI 19.8726
-DI 22.746
Chandelier Exit (Long, 3 ATRs ) 5.1347
Chandelier Exit (Short, 3 ATRs ) 5.7253
Upper Bollinger Band 6.5821
Lower Bollinger Band 4.2499
Percent B (%b) 0.63
BandWidth 43.0613
MACD Line -0.1573
MACD Signal Line -0.2819
MACD Histogram 0.1246
Fundamentals Value
Market Cap 231.32 Million
Num Shares 40.5 Million
EPS -2.42
Price-to-Earnings (P/E) Ratio -2.36
Price-to-Sales 17.96
Price-to-Book 4.50
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.18
Resistance 3 (R3) 6.17 6.00 6.10
Resistance 2 (R2) 6.00 5.88 6.01 6.07
Resistance 1 (R1) 5.86 5.81 5.93 5.87 6.05
Pivot Point 5.69 5.69 5.73 5.70 5.69
Support 1 (S1) 5.55 5.57 5.62 5.56 5.37
Support 2 (S2) 5.38 5.50 5.39 5.35
Support 3 (S3) 5.24 5.38 5.32
Support 4 (S4) 5.25